With investment in modern technology and infrastructure, we are committed to the accuracy and speed of test results, ensuring the best clinical decision making.
AsiaLabs is a leading global diagnostic testing group, constantly striving for excellence in healthcare.
With investment in modern technology and infrastructure, we are committed to the accuracy and speed of test results, ensuring the best clinical decision making.
This is also our commitment in our mission to protect human health for sustainable development.
Let’s build the future of diagnostics together at AsiaLabs. The journey to change your perspective on healthcare starts here.
We value the absolute quality of all services.
We adhere to scientific work principles, always based on facts and objectivity.
We are committed to bringing quality and diverse service experiences to our partners.
Backed by 20+ years of European success
High-quality testing solutions
2000+ clients worldwide
Nguyen Hoang Lab provides high-quality testing services, fully meeting the needs of medical diagnosis.
Nguyen Hoang Lab was established more than 15 years ago by Dr. Nguyen Van Thinh, Head of the Department of Testing at the University of Medicine and Pharmacy, and is one of the prestigious laboratories in Vietnam.
This laboratory is a member of AsiaLabs, ensuring accurate, fast, and safe results for customers.
AnaPath Technology Development Company Limited is a member of AsiaLabs Group.
Established in 2009, after more than 10 years of operation, AnaPath is the leading laboratory in terms of quality of Testing and Pathology in Ho Chi Minh City and the Southern provinces.
With the support of doctors from the University of Medicine and Pharmacy Hospital, Cho Ray Hospital, Oncology Hospital…, we are committed to the diagnostic results: accurate – reliable – fast, optimizing treatment costs for patients.
Why Work With Us?
Vietnam is approaching a demographic transformation that could significantly reshape its healthcare industry. According to the United Nations Population Fund (UNFPA), people aged 60 and older accounted for approximately 11.9%
Vietnamese researchers have identified important differences in breast cancer biomarker testing across hospitals. The findings reveal why laboratory standardisation, specialist expertise and quality assurance are increasingly important to cancer diagnostics
Cancer represents one of Vietnam’s most significant long-term healthcare challenges. According to the International Agency for Research on Cancer (IARC), the GLOBOCAN 2022 estimates identified approximately 180,480 new cancer cases
A pathologist in Vietnam examines a patient specimen under a microscope. Thousands of kilometres away, a specialist in the United States reviews the same microscopic images through a secure video
Vietnam’s diagnostic laboratory industry may represent a significantly larger investment opportunity than many healthcare investors realise. According to market research published by Ken Research in July 2026, Vietnam’s diagnostic laboratory
How TPG Capital Asia’s acquisition of 39 diagnostic laboratories demonstrated the investment potential of Southeast Asian healthcare infrastructure—and what it could mean for Vietnam’s growing pathology industry. In August 2018,